Effect of Short-term Motilitone Therapy on Health-related Quality of Life in Parkinson's Disease Patients With Gastrointestinal Symptoms: a Multicenter, Double-blind Randomized, Placebo-controlled Trial
Latest Information Update: 12 Aug 2020
At a glance
- Drugs DA 9701 (Primary)
- Indications Dyspepsia
- Focus Therapeutic Use
- Acronyms PASS-GI
- 06 Aug 2020 Primary endpoint (Change in the Nepean dyspepsia index-Korean version scores) has been met according to the results published in the Movement Disorders
- 06 Aug 2020 Results published in the Movement Disorders
- 26 Mar 2019 Status changed from recruiting to completed.